Stephen B. Williams, Ashish M

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
European Urology Focus
Volume 61, Issue 6, Pages (June 2012)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
European Urology Oncology
Volume 73, Issue 1, Pages (January 2018)
Volume 61, Issue 5, Pages (May 2012)
Volume 67, Issue 3, Pages (March 2015)
Volume 66, Issue 3, Pages (September 2014)
Volume 70, Issue 6, Pages (December 2016)
Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S
Volume 53, Issue 5, Pages (May 2008)
Volume 66, Issue 6, Pages (December 2014)
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis  Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,
Ashish M. Kamat, Sima Porten  European Urology 
Volume 73, Issue 5, Pages (May 2018)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 4, Pages (April 2013)
European Urology Oncology
European Urology Oncology
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Volume 59, Issue 6, Pages (June 2011)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 68, Issue 1, Pages 5-7 (July 2015)
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal.
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 63, Issue 5, Pages (May 2013)
Volume 71, Issue 5, Pages (May 2017)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 5, Pages (May 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
The Economic Costs of Overactive Bladder in Germany
Volume 69, Issue 6, Pages (June 2016)
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Role of Checkpoint Inhibition in Localized Bladder Cancer
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 74, Issue 4, Pages (October 2018)
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Tamas F. Molnar, Cengiz Gebitekin, Akif Turna 
Epidemiology of Renal Cell Carcinoma
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
European Urology Oncology
The Cost to Medicare of Bladder Cancer Care
European Urology Oncology
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Manfred Wirth, Peter Iversen, David McLeod, William See 
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 54, Issue 1, Pages (July 2008)
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients  Stephen B. Williams, Ashish M. Kamat, Karim Chamie, Michael Froehner, Manfred P. Wirth, Peter N. Wiklund, Peter C. Black, Gary D. Steinberg, Stephen A. Boorjian, Sia Daneshmand, Peter J. Goebell, Kamal S. Pohar, Shahrokh F. Shariat, George N. Thalmann  European Urology Oncology  Volume 1, Issue 2, Pages 91-100 (June 2018) DOI: 10.1016/j.euo.2018.03.005 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Consolidated Standards of Reporting Trials diagram outlining the selection process for inclusion of studies. European Urology Oncology 2018 1, 91-100DOI: (10.1016/j.euo.2018.03.005) Copyright © 2018 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.